Article

Molecular markers in the CSF proteome differentiate neuroinflammatory diseases

2020-04-06

Abstract excerpt

<title>Abstract</title> <p>Background: Multiple sclerosis (MS) is characterized by different degree of inflammatory and neurodegenerative features in the early relapsing vs. progressive subtypes. By using controls with different extent of inflammation vs. neurodegeneration, we examined the CSF proteome to identify molecular markers that differentiate between subtypes of MS. Gene expression of specific proteins we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eb0a167b-ea6d-5f36-8b9c-d803938a8fec
DOI: 10.21203/rs.3.rs-19710/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular markers in the CSF proteome differentiate neuroinflammatory diseasesDOI 10.21203/rs.3.rs-19710/v1Read

Plasma proteome in multiple sclerosis disease progressionSemantic proximity Read

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisSemantic proximity Read

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical SubtypesSemantic proximity Read

Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencingSemantic proximity Read

Novel plasma and brain proteins that are implicated in multiple sclerosisSemantic proximity Read

Comparing Single-Cell Transcriptomes of Blood and Cerebrospinal Fluid Leukocytes in Multiple SclerosisSemantic proximity Read

Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosisSemantic proximity Read

Molecular mechanisms associated with multiple sclerosis progression, severity and phenotypeSemantic proximity Read

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple SclerosisSemantic proximity Read

Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple SclerosisSemantic proximity Read

Proteomic profiling of CSF reveals stage-specific changes in Amyotrophic lateral sclerosis patientsSemantic proximity Read

Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controlsSemantic proximity Read